https://pubmed.ncbi.nlm.nih.gov/39504795/
Discovery of peptidomimetic spiropyrrolidine derivatives as novel 3CLpro inhibitors against...
Given the high pathogenicity and rapid mutation rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is imperative to sustain efforts in...
discoveryderivativesnovelinhibitors